These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3909331)

  • 41. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenems and monobactams: imipenem, meropenem, and aztreonam.
    Hellinger WC; Brewer NS
    Mayo Clin Proc; 1999 Apr; 74(4):420-34. PubMed ID: 10221472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients.
    Smith PF; Ballow CH; Booker BM; Forrest A; Schentag JJ
    Clin Ther; 2001 Aug; 23(8):1231-44. PubMed ID: 11558860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aztreonam: the first monobactam.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa.
    Conrad DA; Williams RR; Couchman TL; Lentnek AL
    Rev Infect Dis; 1991; 13 Suppl 7():S634-9. PubMed ID: 2068473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aztreonam in CAPD peritonitis.
    Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; van Eeckhoute M; Boelaert J; Schurgers M; van Landuyt H; Verbeelen D
    Lancet; 1987 Jul; 2(8552):213-4. PubMed ID: 2885662
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bacterial infections in cancer patients without neutropenia. Comparison between 2 antibiotic combinations (aztreonam and oxacillin versus cefoxitin and tobramycin)].
    Apice G; Beneduce G; Bruni GS; D'Aprile M; Perna M; Silvestro P; Villari P; Pergola M
    Clin Ter; 1989 Nov; 131(3):177-82. PubMed ID: 2533029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
    Sander J
    Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
    [No Abstract]   [Full Text] [Related]  

  • 49. Aztreonam plus clindamycin as therapy for pelvic infections in women.
    Pastorek JG; Cole C; Aldridge KE; Crapanzano JC
    Am J Med; 1985 Feb; 78(2A):47-50. PubMed ID: 4038579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe gram-negative bacterial infections.
    Clergeot A; Steru D; Rosset MA; Carbon C
    J Antimicrob Chemother; 1989 May; 23(5):753-8. PubMed ID: 2759924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience with aztreonam for treatment of infections in children.
    Stutman HR
    Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience.
    Kager L; Nord CE
    Rev Infect Dis; 1985; 7 Suppl 3():S518-21. PubMed ID: 3901215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of aztreonam in serious gram-negative infections.
    Smith G; Bunney RG; Farrell ID; Wood MJ
    J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aztreonam for treating meningitis caused by gram-negative rods.
    Kilpatrick M; Girgis N; Farid Z; Bishay E
    Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aztreonam.
    Tunkel AR; Scheld WM
    Infect Control Hosp Epidemiol; 1990 Sep; 11(9):486-94. PubMed ID: 2230052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical use of tobramycin in patients with surgical infections due to gram-negative bacilli.
    Ishiyama S; Nakayama I; Iwamoto H; Iwai S; Murata I; Ohashi M
    J Infect Dis; 1976 Aug; 134 Suppl():S178-81. PubMed ID: 972279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.